Clinical Trial Update: Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg Once Daily (QD) in the Treatment of Seasonal Allergic Rhinitis (Study P05067)(COMPLETED) [Phase 3]

View source ↗

Summary

A completed Phase 3 placebo-controlled trial evaluating mometasone furoate nasal spray (MFNS) 200 mcg daily for seasonal allergic rhinitis with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Mometasone furoate nasal spray (mometasone furoate)

Snippet

Sponsor: Organon and Co | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2010-05-17